Sarepta Therapeutics Inc (SRPT)
118.97
-0.50
(-0.42%)
USD |
NASDAQ |
Dec 20, 16:00
119.11
+0.14
(+0.12%)
After-Hours: 20:00
Sarepta Therapeutics Total Liabilities (Quarterly): 2.379B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals Inc | 948.74M |
| Eli Lilly and Co | 61.29B |
| Alnylam Pharmaceuticals Inc | 4.173B |
| Catalyst Pharmaceuticals Inc | 111.07M |
| Vertex Pharmaceuticals Inc | 6.609B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.600B |
| Shareholders Equity (Quarterly) | 1.221B |
| Debt to Equity Ratio | 1.005 |
| Current Ratio | 3.839 |
| Net Debt Paydown Yield | 0.01% |